Federal and state funding cuts could affect local farmers' markets
JOHNSON CITY, Tenn. (WJHL) – Ashley Cavender is the Equitable Nutrition and Food Access Director at Appalachian Resource Conservation and Development, or ARC&D.
Cavender said that recent funding freezes and cuts to state programs, as well as proposed funding cuts to federal programs, could affect local farmers' markets and the farmers who rely on them.
'I see on a daily basis how many consumers come to spend their SNAP and benefits at farmers markets, and I see the benefit that the farmers receive in that as well,' said Cavender. 'So, it's also going to affect consumer is being able to come to the market and also it's going to affect their access to whole foods.'
Fort Blackmore United Methodist Camp opening new public pool in Scott Co.
Heather Shipley is the president of the Johnson City Farmers' Market. She says one of the SNAP programs being cut is the Double Up Food Bucks, which doubles the amount of produce you can buy up to $20.
'They're limited now to dollars that they do have at the farmer's market or at the grocery store, wherever they decide to get their food items,' said Shipley. 'If you're not spending that $10 with us, you're going to spend it somewhere else, you're going to look for more bang for your buck.'
Cavender said last year that shoppers spent $19,000 in double-up food bucks at Northeast Tennessee farmers' markets. She also said these cuts will affect farmers who provide the produce for farmers' markets.
'All of that money that is generated just through SNAP and EBT alone is a really large number. So, their income is going to be affected, and we're also seeing where federal funding is being cut for our farmers as well. So, any of those alternative options that they could seek out are also not an option.'
'When it comes to even our programming, we're at risk of having federal funding cuts as well.'
Shipley and Cavender said there are ways the public can help.
'You can actually, as an individual or a company, is sponsor the EBT program yourself, whether you make a onetime donation or you make maybe a seasonal donation,' said Shipley.
'Go to your local farmer,' said Cavender. 'The prices are honestly at this point, probably less. They've always been a little higher. But go to your local farmers markets, go to your local grocery stores and try to purchase this locally as possible, because they're going to need that now more than ever.'
Cavender also said that incentive programs, such as those at farmers' markets, are at risk.
One incentive program is the Farmacy Fit program, offered in partnership with the Tennessee Department of Health.
This grant awards tokens to those who walk a mile at the farmer's market to spend on certain products. Cavender said the Department of Health has delayed the funding cycle, meaning they will not know for sure if ARC&D will receive the grant until July.
Deborah Byrd, executive director of Jonesborough Locally Grown, said they have their own private walking program, called the Farm Fresh Fit Walking Program.
In a statement, Byrd says:
'We are able to continue our private walking program but don't have the funds to last all summer for the number of participants we've had, so we'll have to limit the number of participants until we have more funding.'
Deborah Byrd, executive director of Jonesborough Locally Grown.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Business Upturn
5 hours ago
- Business Upturn
Zydus receives tentative USFDA approval for Rifaximin Tablets, 550 mg
By Aman Shukla Published on June 2, 2025, 08:12 IST Zydus Lifesciences Limited, along with its subsidiaries and affiliates (collectively referred to as 'Zydus'), has received tentative approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Rifaximin Tablets, 550 mg. The approved product is a generic version of Xifaxan® Tablets, 550 mg, which is indicated for the treatment of irritable bowel syndrome with diarrhoea (IBS-D) in adults. The tablets will be manufactured at the company's SEZ II facility in Ahmedabad, India. According to IQVIA MAT data for March 2025, Rifaximin Tablets, 550 mg, recorded annual sales of approximately USD $2,672.9 million in the U.S. market. With this tentative approval, Zydus now has a total of 427 ANDA approvals. Since beginning its ANDA filings in the financial year 2003–04, the company has submitted 492 ANDAs to date. Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at


Business Insider
5 hours ago
- Business Insider
Arcus Biosciences presented data for casdatifan plus cabozantinib
Arcus Biosciences (RCUS) presented the first data for casdatifan plus cabozantinib in an oral presentation by Dr. Toni K. Choueiri, Dana-Farber Cancer Institute, at the 2025 American Society of Clinical Oncology, ASCO, Annual Meeting. Arcus is pursuing a broad development program in both the immuno-oncology-naive and post-IO settings with differentiated combinations to maximize the opportunity for casdatifan in ccRCC. These studies include: Arcus's planned Phase 3 study, PEAK-1, which will evaluate casdatifan plus cabozantinib versus cabozantinib monotherapy as a first- or second-line treatment in patients with metastatic ccRCC who have previously received anti-PD-1/PD-L1 therapy. The primary endpoint will be PFS with a key secondary endpoint of overall survival. eVOLVE-RCC02, a Phase 1b/3 study sponsored by AstraZeneca, which will evaluate casdatifan plus volrustomig, an investigational anti-PD-1/CTLA-4 bispecific antibody, as first-line treatment for participants with ccRCC. ARC-20, which includes three cohorts evaluating casdatifan in earlier-line settings, including casdatifan plus zimberelimab in first-line ccRCC, casdatifan monotherapy in favorable risk ccRCC, and casdatifan monotherapy in immunotherapy-experienced, TKI-naive settings. Confident Investing Starts Here:
Yahoo
6 hours ago
- Yahoo
81-year-old man drowns in home pool
A Shelby County man drowned Sunday after falling into his pool, according to Shelby County Sargent Matt Luthman. [DOWNLOAD: Free WHIO-TV News app for alerts as news breaks] Rescue crews responded to the home on the 17000 block of Mason Road around 6:30 p.m., Luthman said. The man, who was 81-years-old and had a history of Parkinson's disease, slipped and fell into the pool while walking in the backyard with his wife, according to Luthman. The wife flagged down a passing driver who contacted 911. TRENDING STORIES: FBI and law enforcement respond to 'terror attack' in Boulder, Colorado 3 accused of using $600K in stolen SNAP benefits to buy bulk amounts of candy, energy drinks in Ohio Air taxi company opening Dayton facility receives $250 million investment from Toyota Luthman says the pool water was murky, and the victim could not be seen in the water. The man was underwater for 15-20 minutes before rescuers arrived and pulled him from the deep end of the pool, according to Luthman. Crews attempted life saving measures, but they were unsuccessful. The Shelby County Sheriff's Office is investigating the incident, but are considering it an accidental drowning. They have not released the identification of the man. News Center 7 will follow this story. [SIGN UP: WHIO-TV Daily Headlines Newsletter]